EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cholesterol-Lowering Mechanism of Lactobacillus Bile Salt Hydrolase Through Regulation of Bifidobacterium pseudolongum in the Gut Microbiota

Yingying Liu iD, Weijia Kuang, Man Li, Zhihao Wang, Yanrong Liu, Menghuan Zhao, Hailin Huan, Yao Yang iD

Nutrients · 2025

DOI: 10.3390/nu17183019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yingying Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Amidohydrolases, Cholesterol, Bifidobacterium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China; Natural Science Foundation of Jiangsu; Jiangsu Agriculture Science and Technology Innovation Fund, National Key Research and Development Program of China, Natural Science Foundation of Jiangsu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular diseases (CVDs) represent a major global health burden, and cholesterol reduction is a key strategy for their prevention and management. This study investigated the mechanism by which bile salt hydrolase (BSH) from Lactobacilli reduces cholesterol levels by modulating the growth of Bifidobacterium pseudolongum.

Methods

The BSH-recombinant strain YB334 was administered to high-cholesterol-diet mice, and the cholesterol-lowering function of the strain was evaluated by assessing serum cholesterol parameters, including total cholesterol (TC), low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Metagenomic sequencing was used to analyze the gut microbiota, leading to the screening and acquisition of the “responsive” strains affected by BSH. Subsequent investigations were conducted into their cholesterol-lowering effects and mechanisms of action.

Results

Oral administration of the BSH-recombinant strain YB334 can effectively reduce serum cholesterol levels in hypercholesterolemic mice while simultaneously leading to a significant increase in the abundance of B. pseudolongum within the gut microbiota. In vitro experiments indicated that this increased abundance might be closely associated with the strain’s high tolerance to CA, the catalytic product of the BSH enzyme. The BPL-4 strain, obtained through screening, demonstrated cholesterol-lowering efficacy. Mechanistically, BPL-4 altered bile acid pool composition and modulated the farnesoid X receptor (FXR) signaling axis: it suppressed ileal FXR-fibroblast growth factor 15 (FGF15) expression, thereby de-repressing hepatic cholesterol 7α-hydroxylase (CYP7A1) and accelerating cholesterol catabolism into bile acids.

Conclusions

This study provides the first evidence that BSH from lactobacilli can shape the signature gut microbiota by modulating bile acid metabolism via the FXR-CYP7A1 axis, thereby demonstrating a mechanism for its cholesterol-lowering effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeAmidohydrolasesCholesterolBifidobacteriumLactobacillusHypercholesterolemiaAnticholesteremic AgentsAnimalsMiceMaleCholesterol 7-alpha-HydroxylaseFibroblast Growth FactorsMice, Inbred C57BLBile Acids and SaltsReceptors, Cytoplasmic and NuclearProbioticsReceptor, Farnesoid X-Activated

Stichwörter der Autor:innen

Bifidobacterium pseudolongumbile salt hydrolasecholesterol-loweringfarnesoid X receptorgut microbiota

Substanzen

AmidohydrolasesCholesterolCholesterol 7-alpha-HydroxylaseFibroblast Growth FactorsAnticholesteremic AgentsBile Acids and SaltsReceptors, Cytoplasmic and NuclearReceptor, Farnesoid X-Activatedcholoylglycine hydrolasefibroblast growth factor 15, mouse

Autor:innen und Institutionen

  • School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing 210023, China.
  • Nanjing Institute of Product Quality Inspection, Nanjing 210019, China.
  • Jiangsu Academy of Agricultural Sciences, Nanjing 210023, China.

ORCID-Profile: Yingying Liu, Yao Yang

Förderung

  • National Key Research and Development Program of China; Natural Science Foundation of Jiangsu; Jiangsu Agriculture Science and Technology Innovation Fund
  • National Key Research and Development Program of China
  • Natural Science Foundation of Jiangsu
  • Jiangsu Agriculture Science and Technology Innovation Fund

Zitieren

APA

Liu, Y., Kuang, W., Li, M., Wang, Z., Liu, Y., Zhao, M., Huan, H., & Yang, Y. (2025). Cholesterol-Lowering Mechanism of Lactobacillus Bile Salt Hydrolase Through Regulation of Bifidobacterium pseudolongum in the Gut Microbiota. Nutrients. https://doi.org/10.3390/nu17183019

Vancouver

Liu Y, Kuang W, Li M, Wang Z, Liu Y, Zhao M, et al. Cholesterol-Lowering Mechanism of Lactobacillus Bile Salt Hydrolase Through Regulation of Bifidobacterium pseudolongum in the Gut Microbiota. Nutrients. 2025. doi:10.3390/nu17183019

BibTeX
@article{Liu2025,
  author = {Liu, Yingying and Kuang, Weijia and Li, Man and Wang, Zhihao and Liu, Yanrong and Zhao, Menghuan and Huan, Hailin and Yang, Yao},
  title = {Cholesterol-Lowering Mechanism of Lactobacillus Bile Salt Hydrolase Through Regulation of Bifidobacterium pseudolongum in the Gut Microbiota},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17183019}
}
Kostenlos starten →